Unhealthy Medicine-Wash Post_Drug Profits Infect Medical Studies–LA Times
”SO WHY,” he asks, “DID American doctors prescribe $7 billion worth of Vioxx after Merck and the Food and Drug Administration knew all this?”
Search Results for: all
-
-
FDA: NIMH SSRI Study Flawed–No Comparative Untreated Group
Even Dr. Robet Temple, FDA Medical Policy Director of the Center for Drug Evaluation & Research dismisses the claimed finidings of a flawed, but highly trumpeted recent SSRI study published in the American Journal of Psychiatry. The study was sponsored by the National Institute of Mental Health.
-
J & J Failed to Disclose Deaths in Heart Trial
"When you’re talking deaths in clinical trials, mistakes are not an option," said Dr. Arthur Caplan, a medical ethicist at the University of Pennsylvania. "It’s just an area where we have to have absolute, foolproof reporting in place."
-
Surgery Journal to Ban Authors Who Fail to Disclose Conflicts of Interest
"With conflicts of interest increasingly casting doubt on the credibility of medical research, a leading surgery journal is cracking down on authors who fail to disclose links to industry, threatening to temporarily blacklist them."
-
Pharma front ACSH: “Whiny Whistleblower of the Year Award”
2005 was a year in which some of Big Pharma’s clandestine relationships with an army of bought-and- paid- for minions in academia,
government, congress, the media, and front organizations were uncovered–in courtrooms, investigative books, reports and films. -
Top SFBC officials Quit Amid Senate Inquiry Clinical Trials_ Bloomberg News
In its continuing coverage of corrupt clinical drug trial practices, Bloomberg News reports that all three founders of SFBC International, one of the largest clinical trial business operations that had failed to even screen human subjects for turberculosis, and threatened others with deportation if they refused to become guinea pigs, quit after the Senate Finance committee began investigating drug trial safety issues:
-
FDA SSRI Warning
" A causal role for antidepressants in inducing suicidality has been established in pediatric patients."
-
Medical Journal Editor Finds Truth Hard to Track Down
A front page report in The Wall Street Journal underscores the inherent flaw in the "peer review" vetting system used by science journals.
-
PhRMA-“The Karasik Conspiracy”–100 E-mails
The year 2005 will surely be the year in which the pharmaceutical industry’s
dirty tricks and underhanded tactics were revealed for what they are–a
menace to society. -
Comments Re:13 year BMJ investigation of research misconduct
Responding to the AHRP Infomail–Medical Journal Editor Finds Truth Hard to
Track Down (December 27) Eddie Vos,* expert nutrition specialist offers
comments about the13-year ‘"investigation" of alleged research misconduct by
an Indian physician, as reported in the Wall Street Journal (December 27). -
NIMH-funded antidepression drug efficacy / safety studies_What do they prove?
Two studies purporting to report “new encouraging” findings about the efficacy and safety of antidepressants—as tested in the “real world”—were published on Sunday by The American Journal of Psychiatry with an accompanying editorial by Dr. Thomas Insel, director of these studies’ funding agency, the National Institute of Mental Health.
-
NIH Medical Safety Officer Reinstated
The National Institutes of Health's reinstatement of Dr. Jonathan Fishbein settles a two-year battle that prompted both congressional and federal investigations.